Gastric cancer

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Gastric cancer remains one of the most common causes of cancer mortality worldwide, despite a decline in incidence in Western countries. An important recent finding has been the recognition of an association between Helicobacter pylori and gastric cancer. The mechanisms, however, by which H. pylori infection and other environmental factors influence gastric tumorigenesis remain to be elucidated. The recent identification of growth factors and their receptors has provided insights into the regulation of cell growth, proliferation, and differentiation. Furthermore, studies of the effects and interactions of growth factors, oncogenes, and tumor suppressor genes on biological behavior of human gastric cancers are in progress and may aid in therapeutic decision-making. Fortuitously, molecular analysis requires small amounts of tumor tissue, which can be obtained from endoscopic biopsies. Regarding the treatment of gastric cancer, promising data on the use of neoadjuvant chemotherapy to increase surgical resectability have been obtained. However, locoregional failure continues to be the major obstacle and the addition of adjuvant intraperitoneal chemotherapy is specifically aimed at this problem. Novel therapeutic approaches are clearly needed in the management of advanced disease in view of the relatively poor results thus far with available compounds.

Original languageEnglish (US)
Pages (from-to)930-937
Number of pages8
JournalCurrent Opinion in Gastroenterology
Volume9
Issue number6
StatePublished - 1993

Fingerprint

Stomach Neoplasms
Helicobacter pylori
Growth Factor Receptors
Helicobacter Infections
Adjuvant Chemotherapy
Disease Management
Tumor Suppressor Genes
Oncogenes
Cell Differentiation
Neoplasms
Intercellular Signaling Peptides and Proteins
Stomach
Decision Making
Carcinogenesis
Therapeutics
Cell Proliferation
Biopsy
Drug Therapy
Mortality
Incidence

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Gastric cancer. / Sinicrope, Frank A; Levin, B.

In: Current Opinion in Gastroenterology, Vol. 9, No. 6, 1993, p. 930-937.

Research output: Contribution to journalArticle

Sinicrope, FA & Levin, B 1993, 'Gastric cancer', Current Opinion in Gastroenterology, vol. 9, no. 6, pp. 930-937.
Sinicrope, Frank A ; Levin, B. / Gastric cancer. In: Current Opinion in Gastroenterology. 1993 ; Vol. 9, No. 6. pp. 930-937.
@article{1d5cfbbc35554960a27ac7971f36002f,
title = "Gastric cancer",
abstract = "Gastric cancer remains one of the most common causes of cancer mortality worldwide, despite a decline in incidence in Western countries. An important recent finding has been the recognition of an association between Helicobacter pylori and gastric cancer. The mechanisms, however, by which H. pylori infection and other environmental factors influence gastric tumorigenesis remain to be elucidated. The recent identification of growth factors and their receptors has provided insights into the regulation of cell growth, proliferation, and differentiation. Furthermore, studies of the effects and interactions of growth factors, oncogenes, and tumor suppressor genes on biological behavior of human gastric cancers are in progress and may aid in therapeutic decision-making. Fortuitously, molecular analysis requires small amounts of tumor tissue, which can be obtained from endoscopic biopsies. Regarding the treatment of gastric cancer, promising data on the use of neoadjuvant chemotherapy to increase surgical resectability have been obtained. However, locoregional failure continues to be the major obstacle and the addition of adjuvant intraperitoneal chemotherapy is specifically aimed at this problem. Novel therapeutic approaches are clearly needed in the management of advanced disease in view of the relatively poor results thus far with available compounds.",
author = "Sinicrope, {Frank A} and B. Levin",
year = "1993",
language = "English (US)",
volume = "9",
pages = "930--937",
journal = "Current Opinion in Gastroenterology",
issn = "0267-1379",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Gastric cancer

AU - Sinicrope, Frank A

AU - Levin, B.

PY - 1993

Y1 - 1993

N2 - Gastric cancer remains one of the most common causes of cancer mortality worldwide, despite a decline in incidence in Western countries. An important recent finding has been the recognition of an association between Helicobacter pylori and gastric cancer. The mechanisms, however, by which H. pylori infection and other environmental factors influence gastric tumorigenesis remain to be elucidated. The recent identification of growth factors and their receptors has provided insights into the regulation of cell growth, proliferation, and differentiation. Furthermore, studies of the effects and interactions of growth factors, oncogenes, and tumor suppressor genes on biological behavior of human gastric cancers are in progress and may aid in therapeutic decision-making. Fortuitously, molecular analysis requires small amounts of tumor tissue, which can be obtained from endoscopic biopsies. Regarding the treatment of gastric cancer, promising data on the use of neoadjuvant chemotherapy to increase surgical resectability have been obtained. However, locoregional failure continues to be the major obstacle and the addition of adjuvant intraperitoneal chemotherapy is specifically aimed at this problem. Novel therapeutic approaches are clearly needed in the management of advanced disease in view of the relatively poor results thus far with available compounds.

AB - Gastric cancer remains one of the most common causes of cancer mortality worldwide, despite a decline in incidence in Western countries. An important recent finding has been the recognition of an association between Helicobacter pylori and gastric cancer. The mechanisms, however, by which H. pylori infection and other environmental factors influence gastric tumorigenesis remain to be elucidated. The recent identification of growth factors and their receptors has provided insights into the regulation of cell growth, proliferation, and differentiation. Furthermore, studies of the effects and interactions of growth factors, oncogenes, and tumor suppressor genes on biological behavior of human gastric cancers are in progress and may aid in therapeutic decision-making. Fortuitously, molecular analysis requires small amounts of tumor tissue, which can be obtained from endoscopic biopsies. Regarding the treatment of gastric cancer, promising data on the use of neoadjuvant chemotherapy to increase surgical resectability have been obtained. However, locoregional failure continues to be the major obstacle and the addition of adjuvant intraperitoneal chemotherapy is specifically aimed at this problem. Novel therapeutic approaches are clearly needed in the management of advanced disease in view of the relatively poor results thus far with available compounds.

UR - http://www.scopus.com/inward/record.url?scp=0027428148&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027428148&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0027428148

VL - 9

SP - 930

EP - 937

JO - Current Opinion in Gastroenterology

JF - Current Opinion in Gastroenterology

SN - 0267-1379

IS - 6

ER -